Quest
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
In Brief This Week: Thermo Fisher Scientific, Quest Diagnostics, MDxHealth, Renalytix, More
News items for the week of Nov. 13, 2023
360Dx Top 30 Continues Downward Slide, Falling 11 Percent in October
Of the companies in the index, 25 companies saw their share prices decline, while four saw their stock prices rise. One company's share price remained flat.
Quest Diagnostics to Offer $750M of Senior Notes
The firm said the notes are due in 2033 with an interest rate of 6.4 percent, and it plans to use the proceeds for general corporate purposes.
Top Five Articles on 360Dx Last Week: Quest's View on LDT Regulation, PAMA; FDA's LDT Efforts; More
Last week, readers were most interested in a story about how Quest views FDA's plans to regulate LDTs, as well as legislative efforts to reform PAMA.
Oct 24, 2023
Oct 10, 2023
Aug 28, 2023
Jul 25, 2023